Hyponatremia screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]

Overview

Hyponatremia is the most common electrolyte disturbances which are common with certain medical conditions and drugs. Screening the hyponatremia is necessary for preventing further decrease in serum sodium and complications of treatment.

Screening

Plasma sodium should be check in

1–2 weeks after initiation of thiazide, SNRI, and SSRI therapy, especially in patients at high risk for hyponatremia ^[1]^[2]
All hospitalized patients on admission

Check plasma level daily in all patients with hyponatremia
Check plasma level in all patients with risk of hyponatremia

To see the risk factors for developing hyponatremia, click here.

References

↑ T. J. Wilkinson, E. J. Begg, A. C. Winter & R. Sainsbury (1999). “Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people”. British journal of clinical pharmacology. 47 (2): 211–217. PMID 10190657. Unknown parameter |month= ignored (help)
↑ K. M. Chow, C. C. Szeto, T. Y.-H. Wong, C. B. Leung & P. K.-T. Li (2003). “Risk factors for thiazide-induced hyponatraemia”. QJM : monthly journal of the Association of Physicians. 96 (12): 911–917. PMID 14631057. Unknown parameter |month= ignored (help)

Template:WH Template:WS

[1] T. J. Wilkinson, E. J. Begg, A. C. Winter & R. Sainsbury (1999). “Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people”. British journal of clinical pharmacology. 47 (2): 211–217. PMID 10190657. Unknown parameter |month= ignored (help)

[2] K. M. Chow, C. C. Szeto, T. Y.-H. Wong, C. B. Leung & P. K.-T. Li (2003). “Risk factors for thiazide-induced hyponatraemia”. QJM : monthly journal of the Association of Physicians. 96 (12): 911–917. PMID 14631057. Unknown parameter |month= ignored (help)

[1]

[2]